Partnering
MacroGenics is pursuing alliances to participate in development of its proprietary product candidates and technology platforms.
Learn moreIn the News...
See what others are writing or saying about MacroGenics. Learn morePress Releases
2006 Press release Archive
October 16, 2006
MacroGenics Elects Industry Leader, Dr. John Maraganore, to Board of Directors
October 10, 2006
MacroGenics Receives Orphan Drug Designation from FDA for Monoclonal Antibody to Treat Type 1 Diabetes
October 05, 2006
MacroGenics Novel Monoclonal Antibody Shows Potent Anti-tumor Activity against B-Cell Lymphoma in Preclinical Studies
October 02, 2006
MacroGenics receives multiple government awards totaling more than $62 million to advance infectious disease programs
May 17, 2006
MacroGenics Raises $45M in Series C Financing - Company to Advance Monoclonal Antibody Clinical Programs
Press Release Archive: 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | View All